One in four COVID cases in NSW outbreak has been a child under 19 It is clear that Delta is affecting children more than the original coronavirus strain – so how do we protect them?
What now for ivermectin? Professor Andrew McLachlan reviews the medication and its potential against COVID-19 in the wake of a major study being withdrawn.
ATAGI updates AstraZeneca advice as NSW cases increase All adults in Greater Sydney should ‘strongly consider’ the vaccine amid the worsening COVID outbreak, the advisory group said.
TGA updates Pfizer vaccine side effect information Myocarditis and pericarditis were listed as official adverse reactions on the same day the vaccine was approved for use in children aged 12–15.
Locked down Sydneysiders travelling 70km to access COVID vaccines People from Sydney are booking up vaccinations in regional areas, reducing access for those living nearby – including essential workers.
Entering aged care with new GP linked to medication increase In particular, people with dementia are likely to be prescribed more antipsychotics, benzodiazepines and antidepressants if they change their GP.
How are COVID vaccines faring against Delta? New insights from the UK and Israel suggest first generation vaccines may not be as effective, but it’s not all doom and gloom.
Two more deaths linked to AstraZeneca vaccine There have now been six Australian deaths related to the AstraZeneca vaccine, out of more than 6.1 million administered doses.
Half of hospitalised COVID patients develop complications: Research Authors of the large peer-reviewed study warn of ‘important long-term effects’ on the health system.
Poll suggests 93% of GPs have not been offered respirator fit-testing GPs in NSW and Victorian hotspots are being giving access to PPE from the National Medical Stockpile. But with few practices offering fit-testing, how protected are GPs?